Corona's new variant XE has recently knocked in India. This case of the Coronavirus has been found in Mumbai. Now in such a situation, there is a possibility that its infection may spread to other areas of the country. Corona's XE variant has raised concern amid the decreasing cases of the corona.
IN LATE FEBRUARY, the BMC said that the woman had come to India from South Africa and was confirmed to be infected with the XE variant in March. Let us tell you that a case of the Kappa variant of Omicron has also been found. The 376 samples were tested. 230 of them are residents of Mumbai.
The first case of the XE variant of the Omicron variant of COVID-19 has been found in the city. However, patients infected with the new variant do not show severe symptoms. Let us inform you that Omicron has been found in 228 samples out of 230, while one sample has a Kappa variant and one patient has allegedly found an XE variant.
According to the World Health Organization (WHO), the new XE variant was first detected in the United Kingdom (UK) on 19 January. It is a mutant hybrid of two other Omicron variants, ba.1 and ba.2. The WHO has said that this form formed after the change may be more infectious than the former.
The WHO has said that the new mutant is about 10 percent more transmissible than Omicron's ba. Two sub-variant can be more infectious than either strain. Although there are currently few cases of XE worldwide, its extremely high transmission potential could mean that it becomes the most dominant strain shortly.
According to the UK's Health Protection Agency, XE causes symptoms such as runny nose, sneezing, and sore throat, unlike the original strain of the virus. In the original strain, the patient usually complains of fever and cough, and at the same time, he does not taste anything and does not smell any. As of 22 March, 637 cases of XE had been detected in England.
The WHO has said that the data needs to be looked at before anything else can be said about the mutation. According to a report by Forbes, more information is required to make a complete confirmation, according to Susan Hopkins, chief medical adviser to UKHSA. Hopkins said there is still insufficient evidence to draw any conclusions on the infection, its severity, or the vaccine's effectiveness.